Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Ethinylestradiol/drospirenone
Другие языки:

Ethinylestradiol/drospirenone

Подписчиков: 0, рейтинг: 0

Ethinylestradiol/drospirenone
Ethinylestradiol.svg
Ethinylestradiol
Drospirenone.svg
Drospirenone
Combination of
Ethinylestradiol Estrogen
Drospirenone Progestogen; Progestin; Antimineralocorticoid; Antiandrogen
Clinical data
Trade names With 30 μg ethinylestradiol: Yasmin, others
With 20 μg ethinylestradiol: Yaz, Yasminelle, others
Other names EE/DRSP
AHFS/Drugs.com Professional Drug Facts
MedlinePlus a601050
License data
Pregnancy
category
  • AU: B3
Routes of
administration
By mouth
Drug class Estrogen; Progestin; Progestogen; Antimineralocorticoid; Antiandrogen
ATC code
Legal status
Legal status
Identifiers
CAS Number
KEGG

Ethinylestradiol/drospirenone (EE/DRSP), sold under the brand name Yasmin among others, is a combination of ethinylestradiol (EE), an estrogen, and drospirenone (DRSP), a progestin, antimineralocorticoid, and antiandrogen, which is used as a birth control pill to prevent pregnancy in women. It is also indicated for the treatment of moderate acne, premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and dysmenorrhea (painful menstruation) in women. The medication is taken by mouth and contains 30 μg EE and 3 mg DRSP per tablet (brand names Yasmin, others) or 20 μg EE and 3 mg DRSP per tablet (brand names Yaz, Yasminelle, Nikki, others). A formulation with levomefolic acid (vitamin B9) has also been marketed (brand names Beyaz, Safyral, others), with similar indications. EE/DRSP is marketed widely throughout the world.

In 2020, it was the 145th most commonly prescribed medication in the United States, with more than 4 million prescriptions.

See also

External links



Новое сообщение